The rapid development of vaccines to combat severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infections has been critical to reduce the severity of COVID-19 …

The global coronavirus disease 2019 (COVID-19) pandemic caused by the SARS-CoV-2
coronavirus started in March 2020. The conclusions from numerous studies indicate that …

Background As the pandemic evolves, post-acute sequelae of CoV-2 (PASC) including
cardiovascular manifestations have emerged as a new health threat. This study aims to …

COVID‐19 is a systemic infectious disease that may affect many organs, accompanied by a
measurable metabolic dysregulation. The disease is also associated with significant …

This controlled study investigated metabolic changes in non-vaccinated individuals with
Long-COVID-19, along with their connection to the severity of the disease. The study …

Coronavirus disease 2019 (COVID-19) patients show lipid metabolic alterations, but the
mechanism remains unknown. In this study, we aimed to investigate whether the Spike …

Background: Viral infection is associated with a significant rewire of the host metabolic
pathways, presenting attractive metabolic targets for intervention. Methods: We chart the …

Aims The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 virus) affects vital
organs and causes vascular injury. There are concerns that this injury may have long-term …

Background and aims The albumin-to-globulin ratio (AGR) has been used to predict severity
and mortality in infectious diseases. The aim of this study is to evaluate the prognostic value …

Objective Abnormal liver function and liver injury related to COVID-19 during hospitalization
has received widespread attention. However, the long-term observation of patients' liver …